Japan Brain Implants Market Size, Share, and COVID-19 Impact Analysis, By Product (Deep Brain Stimulation, Vagus Nerve Stimulation, and Responsive Neurostimulation), By Application (Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, Schizophrenia, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Japan Brain Implants Market Insights, Industry Trend, Forecasts to 2035

Japan Brain Implants Market Size Insights Forecasts to 2035

• The Japan Brain Implants Market Size Was Estimated at USD 248.4 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 12.14% from 2025 to 2035
• The Japan Brain Implants Market Size is Expected to Reach USD 875.7 Million by 2035

According to a research report published by Spherical Insights & Consulting, the Japan Brain Implants Market Size is anticipated to reach USD 875.7 million by 2035, growing at a CAGR of 12.14% from 2025 to 2035. The Japanese brain implant market is increasing with an increasing population, an increasing rate of neurological conditions, and advances in technology. Japan's rapidly increasing population of elderly people is driving demand for treatments of age-related conditions, while increased healthcare expenditure and governmental efforts are making such advanced technology affordable.

Report Coverage

This research report categorizes the market for the Japan brain implants market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan brain implants market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan brain implants market.

Driving Factors

The Japan brain implants market is fueled by an increasingly aging population, an increasing rate of neurological conditions such as Parkinson's and epilepsy, and an increasing need for minimally invasive surgeries. Technological advancements, including AI-based and wirelessly driven implantable devices, are also propelling growth. Strong healthcare infrastructure and governmental support for neuroscience R&D also contribute significantly. Further, the expansion of clinical applications of brain implants for depression and chronic pain expands adoption, making Japan one of the fastest-growing neurotechnology markets in the Asia-Pacific region.

Restraining Factors

Restraints in Japan's market for brain implants are the high cost of devices, low reimbursement coverage, and surgical complications. Further, ethical concerns and regulatory hurdles to the adoption of neurotechnology hinder the acceptance and commercialization of complex brain implant solutions.

Market Segmentation

The Japan brain implants market share is classified into product, application, and end-user.

• The deep brain stimulation segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan brain implants market is segmented by product into deep brain stimulation, vagus nerve stimulation, and responsive neurostimulation. Among these, the deep brain stimulation segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to it finds application in a variety of applications for neurological diseases. The increasing approval of deep brain stimulators to help manage a variety of neurological diseases, including Parkinson's disease, epilepsy, Alzheimer's disease, and essential tremor, is the key driver of this segment.

• The epilepsy segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan brain implants market is segmented by application into epilepsy, parkinson’s disease, alzheimer’s disease, schizophrenia, and others. Among these, the epilepsy segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is owing to the increasing instances of epilepsy across the globe are significantly driving segment growth. Additionally, increasing investments by firms in the process of creating advanced electrodes with dissolvable coatings, employed to insert flexible implants directly into the brain in a safe manner, are expected to drive further growth in the brain implants segment focused on neurological disorders.

• The hospitals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan brain implants market is segmented by end-user into hospitals, specialty clinics, and others. Among these, the hospitals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the rising number of hospitalizations and surgical procedures for neurological conditions significantly drives segment growth. Furthermore, growing awareness about neurological diseases, increased access to therapy, and ongoing investment in healthcare infrastructure, particularly in emerging economies, further increase growth in this segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan brain implants market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Nihon Kohden Corporation
• Terumo Corporation
• Medtronic
• Nipro Corporation
• Abbott Laboratories
• Olympus Corporation
• Teijin Pharma
• Nevro Corporation
• NeuroPace, Inc.
• Boston Scientific Corporation
• Japan Medical Dynamic Marketing
• Others

Recent Developments:

• In March 2023, Terumo Corporation announced a significant one in launching its Solitaire Neuro Foam Plus, a sophisticated endovascular coiling system.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan brain implants market based on the below-mentioned segments:

Japan Brain Implants Market, By Product

• Deep Brain Stimulation
• Vagus Nerve Stimulation
• Responsive Neurostimulation

Japan Brain Implants Market, By Application

• Epilepsy
• Parkinson’s Disease
• Alzheimer’s Disease
• Schizophrenia
• Others

Japan Brain Implants Market, By End-user

• Hospitals
• Specialty Clinics
• Others